ProCE Banner Activity

Targeting FGFR in Urothelial Cancer and Beyond

Podcast Episodes
Listen to Ignacio Durán, MD, PhD, and Alison Birtle, MD, FRCP, FRCR, discuss the most recent clinical data on targeting FGFR in urothelial cancer and other malignancies.

Released: March 23, 2021

Expiration: March 22, 2022

Share

Faculty

Alison Birtle

Alison Birtle, MD, FRCP, FRCR

Honorary Senior Lecturer
Faculty of Health and Medicine
University of Manchester
Manchester, United Kingdom
Consultant Oncologist
Rosemere Cancer Centre
Lancashire Teaching Hospitals
Preston, Lancashire, United Kingdom

Ignacio Duran

Ignacio Duran, MD, PhD

Associate Professor
GU Oncology Program Leader
Department of Medical Oncology
Hospital Universitario Marques de Valdecilla-Idival
Santander, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Janssen Pharmaceutica NV

Faculty Disclosure

Primary Author

Alison Birtle, MD, FRCP, FRCR

Honorary Senior Lecturer
Faculty of Health and Medicine
University of Manchester
Manchester, United Kingdom
Consultant Oncologist
Rosemere Cancer Centre
Lancashire Teaching Hospitals
Preston, Lancashire, United Kingdom

Ignacio Duran, MD, PhD

Associate Professor
GU Oncology Program Leader
Department of Medical Oncology
Hospital Universitario Marques de Valdecilla-Idival
Santander, Spain